![Yang Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yang Chen
Directeur Général chez Wuxi Langshion Lightweight Technology Co., Ltd.
Postes actifs de Yang Chen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Wuxi Langshion Lightweight Technology Co., Ltd.
![]() Wuxi Langshion Lightweight Technology Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then. | Directeur Général | 01/06/2013 | - |
Fondateur | 01/06/2013 | - |
Historique de carrière de Yang Chen
Statistiques
Internationale
Chine | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Wuxi Langshion Lightweight Technology Co., Ltd.
![]() Wuxi Langshion Lightweight Technology Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then. | Miscellaneous |